Literature DB >> 5871249

Further observation with thalidomide in lepra reactions.

J Sheskin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5871249     DOI： 10.5935/0305-7518.19650036

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


× No keyword cloud information.
  12 in total

Review 1.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Treatment of ulcerative colitis with thalidomide.

Authors:  M F Waters; A B Laing; A Ambikapathy; J E Lennard-Jones
Journal:  Br Med J       Date:  1979-03-24

3.  [What is the relevance of various previous lesions of the peripheral nervous system to a thalidomide polyneuropathy?].

Authors:  G P Liebaldt; F Broser
Journal:  Z Neurol       Date:  1971

4.  Thalidomide--the way forward.

Authors:  J M Gardner-Medwin; R J Powell
Journal:  Postgrad Med J       Date:  1994-12       Impact factor: 2.401

Review 5.  Treatment of leprosy in the United States.

Authors:  W R Levis
Journal:  Bull N Y Acad Med       Date:  1984-09

6.  WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients.

Authors:  C G Iyer; J Languillon; K Ramanujam; G Tarabini-Castellani; J T De las Aguas; L M Bechelli; K Uemura; V Martinez Dominguez; T Sundaresan
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

Review 7.  Thalidomide and its derivatives: emerging from the wilderness.

Authors:  J N Gordon; P M Goggin
Journal:  Postgrad Med J       Date:  2003-03       Impact factor: 2.401

8.  The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.

Authors:  Waqas Rehman; Lisa M Arfons; Hillard M Lazarus
Journal:  Ther Adv Hematol       Date:  2011-10

9.  Nitric oxide rescues thalidomide mediated teratogenicity.

Authors:  Jamila H Siamwala; Vimal Veeriah; M Krishna Priya; Saranya Rajendran; Uttara Saran; Swaraj Sinha; Shunmugam Nagarajan; T Pradeep; Suvro Chatterjee
Journal:  Sci Rep       Date:  2012-09-20       Impact factor: 4.379

Review 10.  Thalidomide: an antineoplastic agent.

Authors:  Robert J Amato
Journal:  Curr Oncol Rep       Date:  2002-01       Impact factor: 5.945
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.